The project, conducted by Michael Kitson of the Judge Institute of Management (Cambridge's Business School) and Dr David Primost of the ESRC Centre for Business Research, revealed a range of competency in handling economic changes and the use of a variety of coping strategies. Researchers worked closely with firms in the biotechnology and aerospace sectors in the UK and observed how they handled economic changes and shocks over three years (2002-2004). This was a period of slow economic growth, but with substantial falls in the valuation of technology-based firms. It also saw major geopolitical developments and events, including the aftermath of 9/11.
"Our aim was to find out how changes in the macroeconomy, and the inevitable shocks that occur, influence managerial behaviour and corporate strategy. We focussed on two high-tech sectors and examined how such behaviours and actions affect competitiveness and long-term growth," said Michael Kitson. "We believe our findings are relevant to mangers and policy makers as different sectors, responded differently; so generalities need to be avoided."
Many biotechnology firms believed that the majority of economic changes had only a negligible impact on them and almost never influenced important decisions, particularly about the development and commercialisation of science. However, one economic variable, the decline in the stock market and hence the availability of finance, did have an impact. Only those firms with large cash reserves felt relatively insulated from changing valuations of their businesses.
To generate new finance, many biotechnology firms tried to increase revenues streams, improve efficiency and many altered their business models. Venture capitalists were, however, stymied by a lack of exit routes for their investments so they only continued to finance firms with technologies in the later stages of development - and therefore closer to market. This caused some firms to drop technology in its early stages - technology that could in the longer term have made a significant contribution to economic growth.
In the aerospace sector there were different perceptions and actions. There was a strong awareness of business cycles and macroeconomic changes. To avoid vulnerability, portfolios of activities driven by different business cycles were developed, and risks were reduced by changing sources of revenue from high value equipment, to an emphasis on after market service and sales. Many made a 'virtue of necessity' in response to world events and pushed through organisational changes such as, reducing excess capacity post 9/11. In addition, the global crisis in aviation was used as an opportunity to implement process improvements and rationalise supply chains.
"In the biotechnology sector, young firms at critical business junctures may lack the competence to cope with changes in financial markets. For these firms, a failure to acquire finance can prevent commercialisation of technology and stunt growth," said Michael Kitson. "In contrast, more mature firms in the aerospace sector have learned more effective business coping strategies. It's important that policy makers take account of these types of differences in their planning."
FOR FURTHER INFORMATION, CONTACT:
Mr Michael Kitson on 01223 338371; 01223 214911 (out of hours); 07803 009377 (mobile) or Email: mk24@cam.ac.uk
Or Lesley Lilley or Becky Gammon at ESRC, on 01793 413119/413122
NOTES FOR EDITORS
1. The research report 'Corporate Responses to Macroeconomic Changes and Shocks' was funded by the Economic and Social Research Council (ESRC) and undertaken at the ESRC Centre for Business Research, Top Floor, The Judge Institute of Management, Trumpington Street, Cambridge, CB2 1AG.
2. The project was carried out over a period of almost three years (2002-2004). Based on real time case studies, an analysis was made of seven aerospace and 14 biotechnology firms. First hand information was obtained via interviews undertaken every two to three months with managers at the firms. In addition, another 24 firms in the two sectors were consulted to help verify the findings, benchmark results and evaluate industry developments. Other data sources (e.g. Aerospace Market Observatory, Biocentury and Factiva) were also drawn on for corporate activity and financial information.
3. The ESRC is the UK's largest funding agency for research and postgraduate training relating to social and economic issues. It provides independent, high-quality, relevant research to business, the public sector and Government. The ESRC invests more than £93million every year in social science and at any time is supporting some 2,000 researchers in academic institutions and research policy institutes. It also funds postgraduate training within the social sciences to nurture the researchers of tomorrow. More at http://www.esrcsocietytoday.ac.uk
4. ESRC Society Today offers free access to a broad range of social science research and presents it in a way that makes it easy to navigate and saves users valuable time. As well as bringing together all ESRC-funded research (formerly accessible via the Regard website) and key online resources such as the Social Science Information Gateway and the UK Data Archive, non-ESRC resources are included, for example the Office for National Statistics. The portal provides access to early findings and research summaries, as well as full texts and original datasets through integrated search facilities. More at http://www.esrcsocietytoday.ac.uk
5. The ESRC confirms the quality of its funded research by evaluating research projects through a process of peer review. Sometimes the ESRC publishes research before this process is finished so that new findings can immediately inform business, Government, media and other organisations. This research is waiting for final comments from academic peers.